Ani Pharmaceuticals has launched Flecainide Acetate tablets.

Flecainide is a Class 1C antiarrhythmic. It is indicated for the prevention of documented, life-threatening ventricular arrhythmias, paroxysmal supraventricular tachycardias (PSVT), and paroxysmal atrial fibrillation/flutter (PAF) in patients without structural heart disease.

RELATED: Pathogenic Variants Role in Arrhythmia Genes Remains Unclear

Flecainide tablets are available in 50mg, 100mg, and 150mg strengths.

For more information call (800) 434-1121 or visit